J. van der Walt

发表

Rescue therapy with high‐dose oral phenobarbitone loading for refractory status epilepticus

M. Karlsson, J. Wilmshurst, J. van der Walt, 2010, Journal of paediatrics and child health.

Esomeprazole FDA Approval in Children With GERD: Exposure-Matching and Exposure-Response

Justin C. Earp, C. Garnett, J. van der Walt, 2017, Journal of pediatric gastroenterology and nutrition.

Population pharmacokinetics of lopinavir and ritonavir in combination with rifampicin-based antitubercular treatment in HIV-infected children

G. Maartens, M. Karlsson, P. Denti, 2010, Antiviral therapy.

Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics.

J. Nachega, M. Karlsson, P. Denti, 2012, British journal of clinical pharmacology.

Effects of Four Different Meal Types on the Population Pharmacokinetics of Single-Dose Rifapentine in Healthy Male Volunteers

D. Mitchison, J. van der Walt, G. Roscigno, 2010, Antimicrobial Agents and Chemotherapy.

Salivary Cortisol Day Curves in Addison’s Disease in Patients on Hydrocortisone Replacement

G. Johannsson, T. Pillay, D. Schatz, 2012, Hormone and Metabolic Research.

Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.

R. Jacobs, J. van der Walt, S. Weller, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Lack of association between stavudine exposure and lipoatrophy, dysglycaemia, hyperlactataemia and hypertriglyceridaemia: a prospective cross sectional study

G. Maartens, J. van der Walt, N. Levitt, 2010, AIDS research and therapy.

Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison’s Disease

D. Blom, G. Johannsson, T. Pillay, 2016, Hormone and Metabolic Research.

Clinical Pharmacokinetic Studies of Enzalutamide

T. Ouatas, Yoshiaki Ohtsu, J. Mordenti, 2015, Clinical Pharmacokinetics.

The interaction between artemether-lumefantrine and lopinavir/ritonavir-based antiretroviral therapy in HIV-1 infected patients

G. Maartens, K. Barnes, K. Mauff, 2015, BMC Infectious Diseases.

The pharmacokinetics of lopinavir/ritonavir when given with isoniazid in South African HIV-infected individuals.

G. Maartens, J. van der Walt, L. Wiesner, 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

The pharmacokinetics of nevirapine when given with isoniazid in South African HIV-infected individuals.

G. Maartens, R. Wilkinson, P. Denti, 2013, The International Journal of Tuberculosis and Lung Disease.

Therapeutic drug monitoring of antiretrovirals for people with HIV.

J. van der Walt, K. Cohen, N. Siegfried, 2009, The Cochrane database of systematic reviews.

Interaction between Artemether-Lumefantrine and Nevirapine-Based Antiretroviral Therapy in HIV-1-Infected Patients

G. Maartens, K. Barnes, K. Mauff, 2011, Antimicrobial Agents and Chemotherapy.

Population Pharmacokinetic Model for Adherence Evaluation Using Lamivudine Concentration Monitoring

M. Karlsson, P. Denti, J. van der Walt, 2012, Therapeutic drug monitoring.

Pharmacokinetic Drug Interaction Studies with Enzalutamide

T. Ouatas, Yoshiaki Ohtsu, J. Mordenti, 2015, Clinical Pharmacokinetics.

Japanese subgroup analysis of the phase 3 MONARCH 3 study of abemaciclib as initial therapy for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer

E. Tokunaga, M. Goetz, Masato Takahashi, 2021, Breast Cancer.

Japanese subpopulation analysis of MONARCH 2: phase 3 study of abemaciclib plus fulvestrant for treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that progressed on endocrine therapy

G. Sledge, H. Iwata, H. Mukai, 2021, Breast Cancer.

Population Pharmacokinetics of Ethambutol in South African Tuberculosis Patients

Siv Jönsson, Mats O. Karlsson, Ulrika S. H. Simonsson, 2011, Antimicrobial Agents and Chemotherapy.

A Nonlinear Mixed Effects Pharmacokinetic Model for Dapagliflozin and Dapagliflozin 3-O-glucuronide in Renal or Hepatic Impairment

M O Karlsson, M. Karlsson, J. van der Walt, 2013, CPT: pharmacometrics & systems pharmacology.

Identification of the primary mechanism of action of an insulin secretagogue from meal test data in healthy volunteers based on an integrated glucose-insulin model

J. van der Walt, M. Kjellsson, S. Choy, 2012, Journal of Pharmacokinetics and Pharmacodynamics.

Guidelines for the Quality Control of Population Pharmacokinetic–Pharmacodynamic Analyses: an Industry Perspective

P. L. Bonate, A. Strougo, A. Desai, 2012, The AAPS Journal.

Development and Application of a Mechanistic Population Modeling Approach to Describe Abemaciclib Pharmacokinetics

M. Posada, J. van der Walt, P. K. Turner, 2020, CPT: pharmacometrics & systems pharmacology.

A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins

Maciej J. Swat, Craig J. Thalhauser, B. Small, 2019, CPT: pharmacometrics & systems pharmacology.

Integration of data from multiple sources for simultaneous modelling analysis: experience from nevirapine population pharmacokinetics.

J. Nachega, M. Karlsson, P. Denti, 2012, British Journal of Clinical Pharmacology.